Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Spreadsheets are powerful tools for investment planning. Discover how to utilize them to track and manage your investments efficiently.
20,347 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A 65-year-old Bay Area tech veteran considers retirement with a sizeable real estate stake and a $915k retirement cus...
The Fed is dialed into inflation that won’t quit. Even with cooling CPI numbers, prices stay stubborn in key areas. H...
Imagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
A hypothetical summer of mega-deals could redefine streaming. This article explains what Netflix should consider if F...
Investors pulled funds for the fourth consecutive week from crypto investment products, totaling $173 million. Yet XR...
One rental property changed everything for a seasoned investor. This article reveals the smart loans, disciplined hab...
A big fund trimmed its ACMR stake, yet the stock jumped 170% in a short window. This article breaks down what happene...
MARA has closed a deal to acquire a controlling stake in Exaion's French data center unit, boosting MARA's European i...
Investors chasing income with growth potential often look for a reliable pillar. This elite 5.5%-yielding dividend of...
Institutional moves shape the AI stock landscape. This article dives into Philippe Laffont’s Coatue strategy, why Nvi...
Grail stock showed a notable bounce after several tough sessions tied to trial updates. This piece breaks down what’s...